New device for leg clots tested in first human survey

NCT ID NCT07335341

Recruiting now Knowledge-focused Sponsor: Medtronic Endovascular Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Aug 12, 2026 · Updated 4 times

Summary

This study surveys doctors who use the Liberant system to remove fresh blood clots from leg arteries and veins. About 50 patients aged 22 or older will be treated within 72 hours of their procedure. The goal is to confirm the device is safe and works as intended.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE DVT OF LOWER EXTREMITY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute respiratory distress syndrome Arterial Occlusive Diseases disease limb ischemia peripheral arterial disease peripheral vascular disease thrombotic disease vascular disorder venous thromboembolism Venous Thrombosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACUTE DVT OF LOWER EXTREMITY ACUTE LIMB ISCHEMIA ARTERIAL EMBOLISM AND THROMBOSIS CHRONIC DVT OF LOWER EXTREMITY DEEP VEIN THROMBOSIS LEG DVT LE ALI LOWER EXTREMITY ACUTE LIMB ISCHEMIA PERIPHERAL ARTERIAL DISEASE THROMBUS IN THE PERIPHERAL VENOUS VASCULATURE VENOUS EMBOLISM OF LOWER EXTREMITIES (DIAGNOSIS)

Contacts and locations

Locations

Baylor Heart Hospital Of Plano
RECRUITING

Plano, Texas, 75093, United States
MedStar Health
RECRUITING

Washington D.C., District of Columbia, 003329, United States
Mount Sinai
RECRUITING

New York, New York, 10029, United States
Naples Comprehensive Health
RECRUITING

Naples, Florida, 34108, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.